Business Units

Equity Pharmaceuticals

>Equity Pharmaceuticals is the prescription product division of Clinigen South Africa.

Our core range of essential medicines is used to meet an ever-expanding mix of medical needs in a variety of therapeutic areas. Equity Pharmaceuticals currently has niche products in the following therapeutic areas: Gastroenterology, Substance, Abuse, Allergy, Cardiology, Anaphylaxis, Analgesia/Anesthesia, Anti-infective, Endocrinology, ENT, Intensive care, Metabolic disease, Neurology, Oncology, Orphan Drugs, Transplantation and Toxicology. Equity Pharmaceuticals supports Pharmacists and Physicians by sourcing and supplying Section 21 medicines both locally and internationally. We also specialize in products for the treatment of ulcerative colitis and for the symptomatic treatment of bowel spasms and bloating in irritable bowel syndrome as well as products assisting with the treatment of opiate narcotic addiction.